• Latest News

  • Latest News

Norgine Ventures completes €5 million Financing with Q3 Medical Devices

London, England, June 21, 2016 – Q3 Medical Devices today announced that it has received financing of up to €5million from Norgine Ventures. This investment recognises the growth prospects of Q3 Medical Devices, an Irish based holding company with multiple operations in Germany focused on the development, manufacturing and distribution of minimally invasive devices for […]

Norgine Ventures Announces Successful Conclusion of its Investment in Stanmore Implants

London. 17 May 2016, 07:00 am BST. Norgine Ventures announced that it has successfully exited its investment in Stanmore Implants Worldwide Limited (SIW) following the acquisition of SIW by Stryker Corporation (“Stryker”) in an all cash transaction for £35.6m. Stanmore Implants is an orthopaedics company focused on the specialist design and manufacture of patient-specific implants […]

Norgine Ventures Announces Successful Conclusion of its Investment in Innovative Pharma Company Internis

London. 12 January 2015, 09.00 AM GMT.  Norgine Ventures today announced that it has successfully exited its investment in Internis Pharmaceuticals Limited following the acquisition of Internis by an undisclosed pharmaceutical company in December 2014. This transaction represents a significant achievement for this exciting and innovative British company. Internis, founded in 2010 by Charles Tannenbaum, […]

Norgine Ventures completes €4 million financing with SpineVision SA

London. 3 November 2014, 07:00 AM BST. Norgine Ventures today announced that it has provided financing of €4 million to SpineVision SA. The financing was realised in form of private bonds with warrants. Norgine Ventures is a business entity of Norgine, a European specialist pharmaceutical company. Norgine Ventures’ investment will help SpineVision finance development of […]

Norgine Ventures completes €7 million financing with Azanta Danmark A/S

London. Monday 13 October 2014. 07:00 AM BST. Norgine Ventures today announced that it has provided financing of up to €7million to Azanta Danmark A/S. This investment recognises the growth prospects of Azanta, a specialty pharma company marketing oncology, women’s health and addiction medicine products. The funding will help Azanta finance its late-stage clinical development […]

Norgine Ventures Completes €15 Million Financing With Agendia N.V.

London. 14 March 2014. Norgine Ventures today announced that, together with a number of Agendia’s existing shareholders, it has provided debt financing of €15 million to Agendia NV, with Norgine leading the syndicate. This investment recognises the growth prospects of Agendia, a molecular diagnostic company marketing a suite of breast and colon cancer tests. The […]